Enzo Biochem Profit Margin

Enzo Biochem (ENZ) currently reports a profit margin of -76.73% as of April 2025. That compares with 947.53% in the prior-year period — down 108.1% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Enzo Biochem's profit margin history and peer comparisons.

Enzo Biochem's profit margin decreased from 947.53% to -76.73% — a 108.1% year-over-year decrease (period ending April 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enzo Biochem's profit margin of -76.73% is lower than the Healthcare sector average of 13.76%. That is roughly 657.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Enzo Biochem's current -76.73% should be judged against Healthcare norms (sector average: 13.76%) and against ENZ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -76.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Enzo Biochem, and consider following ENZ for alerts when major investors trade the stock.